Amgen (AMGN) Receives a Buy from Bernstein
I'm PortAI, I can summarize articles.
Bernstein analyst Courtney Breen maintained a Buy rating on Amgen with a price target of $335. Piper Sandler's David Amsellem also issued a Buy rating, while Truist Financial maintained a Hold rating. Breen, focusing on healthcare stocks, has a 20.1% average return and an 89.19% success rate. The news highlights analyst opinions and ratings on Amgen's stock.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments